INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 42h ago
House PTR2h ago
SEC 13F2h ago
Robinhood Chain2h ago

Results

20,929 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
22
BH
Blumenthal Neil HarrisDirector, Co-Chief Executive Officer
WRBYWarby Parker Inc.
Open-market sale · 10b5-1 plan
SELL$1.09M
36.3K sh
Jun 29, 2026Jul 1, 2026
traded Jun 29, 2026
+2dSEC Form 4

Evidence

Page 219 of 524
← PrevNext →
21
PD
Paul Josh D.Chief Accounting Officer
PANWPalo Alto Networks Inc
Open-market sale · 10b5-1 plan
SELL
$311K
900 sh
Jul 1, 2026
Jul 1, 2026
traded Jul 1, 2026
+0d
SEC Form 4

Evidence

21
BF
Barone FrancescaChief Scientific Officer
CADLCandel Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$236K
23.4K sh
Jun 29, 2026Jul 1, 2026
traded Jun 29, 2026
+2dSEC Form 4

Evidence

20
SB
Sousa Mauad BrunoDirector
AUGOAura Minerals Inc.
Open-market sale
SELL$552K
26.6K sh
Jun 30, 2026Jul 1, 2026
traded Jun 30, 2026
+1dSEC Form 4

Evidence

19
TR
ten Bosch John RoderickSVP of Laboratory Operations
BLLNBillionToOne, Inc.
Open-market sale · 10b5-1 plan
SELL$170K
1,416 sh
Jun 29, 2026Jul 1, 2026
traded Jun 29, 2026
+2dSEC Form 4

Evidence

17
TS
Tyagarajan SeshuChief Technology Officer
CADLCandel Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$70K
7,000 sh
Jun 29, 2026Jul 1, 2026
traded Jun 29, 2026
+2dSEC Form 4

Evidence

14
DA
Dandekar AtulCSBO
MAZEMaze Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$210K
7,500 sh
Jun 29, 2026Jul 1, 2026
traded Jun 29, 2026
+2dSEC Form 4

Evidence

1
CK
Clark KyleDirector, SEE REMARKS
BETABETA Technologies, Inc.
Open-market sale · 10b5-1 plan
SELL$249K
15.0K sh
Jun 30, 2026Jul 1, 2026
traded Jun 30, 2026
+1dSEC Form 4

Evidence

1
CK
Clark KyleDirector, SEE REMARKS
BETABETA Technologies, Inc.
Open-market sale · 10b5-1 plan
SELL$246K
15.0K sh
Jun 29, 2026Jul 1, 2026
traded Jun 29, 2026
+2dSEC Form 4

Evidence

1
BK
Bliss KellyPresident, U.S. Group Health
TDOCTeladoc Health, Inc.
Open-market sale · 10b5-1 plan
SELL$23K
2,500 sh
Jul 1, 2026Jul 1, 2026
traded Jul 1, 2026
+0dSEC Form 4

Evidence

1
MP
McNamara PeterChief Scientific Officer
TECXTectonic Therapeutic, Inc.
Open-market sale · 10b5-1 plan
SELL$6,020
172 sh
Jun 30, 2026Jul 1, 2026
traded Jun 30, 2026
+1dSEC Form 4

Evidence

50
RZ
Richmond Raphaell Z.VP, GC & Chief Compliance Off
LZBLA-Z-BOY INC
Open-market sale
SELL$545K
13.7K sh
Jun 29, 2026Jun 30, 2026
traded Jun 29, 2026
+1dSEC Form 4

Evidence

44
HA
Hunt Jolie A.Director
NYSEKRCKILROY REALTY CORP
Open-market sale
SELL$597K
15.8K sh
Jun 29, 2026Jun 30, 2026
traded Jun 29, 2026
+1dSEC Form 4

Evidence

41
WE
Warren EricChief Commercial Officer
MLYSMineralys Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$2.70M
104.1K sh
Jun 26, 2026Jun 30, 2026
traded Jun 26, 2026
+4dSEC Form 4

Evidence

40
KK
Kalia KumudChief Information Officer
GHGuardant Health, Inc.
Open-market sale
SELL$79K
600 sh
Jun 10, 2026Jun 30, 2026
traded Jun 10, 2026
+20dSEC Form 4

Evidence

39
TP
Topline Capital Partners, LP10% Owner
NRDSNERDWALLET, INC.
Open-market sale
SELL$8.23M
919.2K sh
Jun 26, 2026Jun 30, 2026
traded Jun 26, 2026
+4dSEC Form 4

Evidence

39
Topline Capital Management, LLCSee Explanation in Footnotes
NRDSNERDWALLET, INC.
Open-market sale
SELL$8.23M
919.2K sh
Jun 26, 2026Jun 30, 2026
traded Jun 26, 2026
+4dSEC Form 4

Evidence

37
KK
Kalia KumudChief Information Officer
GHGuardant Health, Inc.
Open-market sale
SELL$79K
600 sh
Jun 15, 2026Jun 30, 2026
traded Jun 15, 2026
+15dSEC Form 4

Evidence

35
Topline Capital Management, LLCSee Explanation in Footnotes
NRDSNERDWALLET, INC.
Open-market sale
SELL$5.42M
587.8K sh
Jun 29, 2026Jun 30, 2026
traded Jun 29, 2026
+1dSEC Form 4

Evidence

35
TP
Topline Capital Partners, LP10% Owner
NRDSNERDWALLET, INC.
Open-market sale
SELL$5.42M
587.8K sh
Jun 29, 2026Jun 30, 2026
traded Jun 29, 2026
+1dSEC Form 4

Evidence

35
Topline Capital Management, LLCSee Explanation in Footnotes
NRDSNERDWALLET, INC.
Open-market sale
SELL$4.22M
454.9K sh
Jun 30, 2026Jun 30, 2026
traded Jun 30, 2026
+0dSEC Form 4

Evidence

35
TP
Topline Capital Partners, LP10% Owner
NRDSNERDWALLET, INC.
Open-market sale
SELL$4.22M
454.9K sh
Jun 30, 2026Jun 30, 2026
traded Jun 30, 2026
+0dSEC Form 4

Evidence

34
TA
Tpg Gp A, LlcFormer 10% Owner
CBLLCeribell, Inc.
Open-market sale
SELL$4.07M
202.4K sh
Jun 26, 2026Jun 30, 2026
traded Jun 26, 2026
+4dSEC Form 4

Evidence

33
CA
Cruces Jorge AlbertoChief Investment Officer
IRSIRSA INVESTMENTS & REPRESENTATIONS INC
Open-market sale
SELL$38K
24.9K sh
Jun 30, 2026Jun 30, 2026
traded Jun 30, 2026
+0dSEC Form 4

Evidence

32
MS
Manor SagitCFO
NYAXNayax Ltd.
Open-market sale
SELL$5,058
79 sh
Jun 26, 2026Jun 30, 2026
traded Jun 26, 2026
+4dSEC Form 4

Evidence

32
GS
Greenberg Aaron SamuelCSO
NYAXNayax Ltd.
Open-market sale
SELL$3,448
54 sh
Jun 29, 2026Jun 30, 2026
traded Jun 29, 2026
+1dSEC Form 4

Evidence

32
TO
Tepper OrenCRO
NYAXNayax Ltd.
Open-market sale
SELL$3,649
57 sh
Jun 26, 2026Jun 30, 2026
traded Jun 26, 2026
+4dSEC Form 4

Evidence

32
HW
Hu Da-WaiGeneral Counsel & Secretary
CHWYChewy, Inc.
Open-market sale
SELL$80K
4,103 sh
Jun 29, 2026Jun 30, 2026
traded Jun 29, 2026
+1dSEC Form 4

Evidence

32
FL
Furman Carly LisanneCEO NAYX North America
NYAXNayax Ltd.
Open-market sale
SELL$7,008
110 sh
Jun 26, 2026Jun 30, 2026
traded Jun 26, 2026
+4dSEC Form 4

Evidence

32
SM
Sever MichalCMO
NYAXNayax Ltd.
Open-market sale
SELL$2,236
35 sh
Jun 29, 2026Jun 30, 2026
traded Jun 29, 2026
+1dSEC Form 4

Evidence

32
TO
Tepper OrenCRO
NYAXNayax Ltd.
Open-market sale
SELL$4,721
74 sh
Jun 29, 2026Jun 30, 2026
traded Jun 29, 2026
+1dSEC Form 4

Evidence

31
RR
Roath Lisa RExecutive Officer
TGTTARGET CORP
Open-market sale
SELL$966K
7,000 sh
Jun 29, 2026Jun 30, 2026
traded Jun 29, 2026
+1dSEC Form 4

Evidence

31
MS
Morris Matthew ShawnDirector
PRVAPrivia Health Group, Inc.
Open-market sale · 10b5-1 plan
SELL$2.23M
88.1K sh
Jun 26, 2026Jun 30, 2026
traded Jun 26, 2026
+4dSEC Form 4

Evidence

29
CM
Colendich Katie MarieGC, Corporate Secretary
ASANAsana, Inc.
Open-market sale
SELL$35K
5,242 sh
Jun 26, 2026Jun 30, 2026
traded Jun 26, 2026
+4dSEC Form 4

Evidence

29
MS
Manor SagitCFO
NYAXNayax Ltd.
Open-market sale
SELL$14K
214 sh
Jun 29, 2026Jun 30, 2026
traded Jun 29, 2026
+1dSEC Form 4

Evidence

29
FL
Furman Carly LisanneCEO NAYX North America
NYAXNayax Ltd.
Open-market sale
SELL$7,022
109 sh
Jun 29, 2026Jun 30, 2026
traded Jun 29, 2026
+1dSEC Form 4

Evidence

28
BS
Benzeno SharonChief Commercial Ofc Imm Med
ADPTAdaptive Biotechnologies Corp
Open-market sale · 10b5-1 plan
SELL$3.27M
154.8K sh
Jun 29, 2026Jun 30, 2026
traded Jun 29, 2026
+1dSEC Form 4

Evidence

27
BM
Buczkowski MichelleChief Administration Officer
EOSEEos Energy Enterprises, Inc.
Open-market sale · 10b5-1 plan
SELL$67K
11.5K sh
Jun 30, 2026Jun 30, 2026
traded Jun 30, 2026
+0dSEC Form 4

Evidence

26
CJ
Congleton JonDirector, Chief Executive Officer
MLYSMineralys Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$1.50M
58.0K sh
Jun 30, 2026Jun 30, 2026
traded Jun 30, 2026
+0dSEC Form 4

Evidence

24
VD
Vilsack Robert DSecretary & CLO
PKOHPARK OHIO HOLDINGS CORP
Open-market sale
SELL$119K
3,100 sh
Jun 26, 2026Jun 30, 2026
traded Jun 26, 2026
+4dSEC Form 4

Evidence